Journal
EXPERT REVIEWS IN MOLECULAR MEDICINE
Volume 24, Issue -, Pages -Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1017/erm.2022.30
Keywords
Angiogenesis; development; JMJD6; placenta; pregnancy
Funding
- National Natural Science Foundation of China [81901487]
- Repronatal Foundation, Basel, Switzerland
Ask authors/readers for more resources
Proper placental development and function are crucial for the health of both the mother and the fetus during pregnancy. JMJD6, along with other angiogenic factors, plays a significant role in regulating placental angiogenesis. Understanding the interaction between JMJD6 and other placental factors may identify potential therapeutic targets for correcting abnormal placental angiogenesis and function.
Correct placental development and function are critical to both the mother's and the foetus' health during pregnancy. Placental function depends on the correct development of the vascular network, which requires proper angiogenesis. Impaired angiogenesis in the placenta can induce foetal growth restriction, preeclampsia, and even foetal death. Placental angiogenesis is finely controlled by ubiquitous and pregnancy-specific angiogenic factors. Jumonji domain-containing protein 6 (JMJD6) is a Fe (II)- and 2-oxoglutarate (2OG)-dependent oxygenase that catalyses arginine demethylation and lysine hydroxylation of histone and non-histone peptides. JMJD6 has been implicated in embryonic development, cellular proliferation and migration, self-tolerance induction in the thymus, and adipocyte differentiation. In this review we present JMJD6's structure and activity, as well as its role in angiogenesis, oxygen sensing, and adverse pregnancy outcomes related to placental development. Understanding the interaction between JMJD6 and other placental factors may identify potential therapeutic targets for correcting abnormal placental angiogenesis and function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available